Filter posts

BIO 2019 Innovation Zone Company Snapshot: HealthRhythms, Inc.

The next big medical breakthrough is on the horizon and all it takes is one …

Important Perspectives on Innovation and Costs

This is an exciting time in biomedical innovation. New and highly innovative therapies are coming …

New BIO Report on State of Innovation for Alzheimer’s Disease Therapeutics

Today, BIO released a new report: The State of Innovation in Highly Prevalent Chronic Diseases …

“Health Care’s Big Spending Mismatch”

This week, Axios reported on new data that shows “the health care services that rack …

New Guide to Help Consumers Navigate Genetic Health Testing

In recent years, we have seen a growing array of direct-to-consumer (DTC) genetic testing products …

Promising Results Offer Hope in Fight Against Candida auris

While health care conversations on Capitol Hill today are largely focused on how to best …

Setting the Record Straight on March-In Rights

In a recent piece for The Washington Post, author Christopher Rowland inaccurately suggested that the federal government …

WSJ: Drug Importation is “Impractical, Unsafe and Unlikely” to Lower Prices

This week, Editorial Board writers for The Wall Street Journal examined a policy proposal in …

Greenwood: In Pharma Value Chain, PBMs Manage to Benefit

Writing for The Hill, BIO’s President and CEO Jim Greenwood offered praise to the Senate Finance …

BIO Calls Rebate Rule a “Significant Step Forward” for Patients

The Biotechnology Innovation Organization (BIO) this week lauded an administration proposal that would be a …